Attachment 1. Product Information for Dimethyl Fumarate
Secondary endpoints at 2 years included the number of new or newly enlarging T2 hyperintense lesions, number of Gd-enhancing lesions, annualised relapse rate (ARR), and time to confirmed disability progression. Confirmed disability progression was defined as at least a 1 point increase from baseline EDSS (1.5 point increase for patients with ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- attachment 1 product information for dimethyl fumarate
- national pbm monograph template rev20091005
- viktor s notes multiple sclerosis
- table 1 cns involvement by waldenstrom s
- london school of hygiene tropical medicine
- temporal lesions aim group
- anatomy and pathology of the cerebellar peduncle
- 1h mrs quantitation of na and cr in the normal appearing
- in
Related searches
- watershed information for kids
- new product ideas for students
- health information for senior citizens
- background information for science projects
- heart health information for seniors
- nutritional information for starbucks
- reverse mortgage information for dummies
- medical information for seniors
- 1 product website
- product information sheet sample
- product information sheet template
- product information sheet template free